Prostatis Group LLC Pfizer Inc Transaction History

Prostatis Group LLC

$215 Billion
Q2 2023

A detailed history of Prostatis Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Prostatis Group LLC holds 28,272 shares of PFE stock, worth $755,993. This represents 0.06% of its overall portfolio holdings.

Number of Shares

28,272

Holding current value

$755,993

% of portfolio

0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $1.02 Million - $1.18 Million	28,272 New	28,272 $132 Million
Q4 2022 Mar 28, 2023	SELL	$41.75 - $54.5 $334 - $436	-8 Reduced 0.14%	5,893 $302 Million
Q4 2022 Mar 23, 2023	BUY	$41.75 - $54.5 $767,991 - $1 Million	18,395 Added 16.64%	128,960 $302 Million
Q3 2022 Mar 28, 2023	BUY	$43.76 - $53.42 $23,761 - $29,007	543 Added 10.13%	5,901 $258 Million
Q3 2022 Mar 23, 2023	SELL	$43.76 - $53.42 $963,245 - $1.18 Million	-22,012 Reduced 16.6%	110,565 $258 Million
Q2 2022 Mar 28, 2023	SELL	$46.53 - $55.17 $39,736 - $47,115	-854 Reduced 13.75%	5,358 $281 Million
Q2 2022 Mar 23, 2023	BUY	$46.53 - $55.17 $106,507 - $126,284	2,289 Added 1.76%	132,577 $281 Million
Q1 2022 Mar 28, 2023	BUY	$45.75 - $56.69 $39,756 - $49,263	869 Added 16.26%	6,212 $322 Million
Q1 2022 Mar 23, 2023	SELL	$45.75 - $56.69 $768,920 - $952,788	-16,807 Reduced 11.43%	130,288 $322 Million
Q4 2021 Mar 28, 2023	BUY	$41.32 - $61.25 $3,429 - $5,083	83 Added 1.58%	5,343 $315 Million
Q4 2021 Mar 23, 2023	BUY	$41.32 - $61.25 $1.62 Million - $2.41 Million	39,316 Added 36.48%	147,095 $315 Million
Q3 2021 Mar 28, 2023	SELL	$39.25 - $50.42 $24,649 - $31,663	-628 Reduced 10.66%	5,265 $226 Million
Q3 2021 Mar 23, 2023	BUY	$39.25 - $50.42 $371,815 - $477,628	9,473 Added 9.64%	107,779 $226 Million
Q2 2021 Mar 28, 2023	SELL	$35.91 - $40.68 $10,772 - $12,204	-300 Reduced 5.4%	5,260 $206 Million
Q2 2021 Mar 23, 2023	BUY	$35.91 - $40.68 $248,712 - $281,749	6,926 Added 7.58%	98,306 $206 Million
Q1 2021 Mar 28, 2023	SELL	$33.49 - $37.77 $4.13 Million - $4.66 Million	-123,400 Reduced 95.69%	5,560 $201 Million
Q1 2021 Mar 23, 2023	SELL	$33.49 - $37.77 $45,613 - $51,442	-1,362 Reduced 1.47%	91,380 $201 Million
Q4 2020 Mar 23, 2023	BUY	$33.47 - $42.56 $203,798 - $259,147	6,089 Added 7.03%	92,742 $203 Million
Q3 2020 Mar 23, 2023	BUY	$31.75 - $37.25 $484,346 - $568,248	15,255 Added 21.37%	86,653 $189 Million
Q2 2020 Mar 23, 2023	BUY	$30.12 - $36.54 $5,692 - $6,906	189 Added 0.27%	71,398 $150 Million
Q1 2020 Mar 23, 2023	BUY	$27.03 - $38.62 $1.92 Million - $2.75 Million	71,209 New	71,209 $147 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.8 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.77 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.38 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.48 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Account